Package 45963-142-90

{"route": ["ORAL"], "spl_id": "50d33e34-1a33-4595-b06a-4da2f7d7d518", "openfda": {"upc": ["0345963142306"], "unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["df923448-4f81-47af-8e55-f7359746b05f"], "manufacturer_name": ["Actavis Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (45963-142-05)", "package_ndc": "45963-142-05", "marketing_start_date": "20150519"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (45963-142-30)", "package_ndc": "45963-142-30", "marketing_start_date": "20150217"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (45963-142-90)", "package_ndc": "45963-142-90", "marketing_start_date": "20150615"}], "brand_name": "Bupropion Hydrochloride", "product_id": "45963-142_50d33e34-1a33-4595-b06a-4da2f7d7d518", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "45963-142", "generic_name": "Bupropion Hydrochloride", "labeler_name": "Actavis Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA077285", "marketing_category": "ANDA", "marketing_start_date": "20150217", "listing_expiration_date": "20271231"}